SREBF1 and glioblastoma: Interestingly, activation of SREBP1 and enhanced expression of lipogenic genes have been observed in human glioblastoma multiforme (GBM) carrying activating mutations in the epidermal growth factor receptor (EGFR) and inhibition of lipid synthesis blocked xenograft growth of glioblastoma cells expressing mutant EGFR [10].